National Health Investors
224 hedge funds and large institutions have $1.98B invested in National Health Investors in 2018 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 90 increasing their positions, 63 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
224
Holders Change
+10
Holders Change %
+4.67%
% of All Funds
5.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
90
Reduced
63
Closed
23
Calls
$8.15M
Puts
$11.7M
Net Calls
-$3.56M
Net Calls Change
+$3.46M
Top Buyers
1 |
Principal Financial Group
Des Moines,
Iowa
|
+$33.6M |
2 |
HCM
Hamlin Capital Management
New York
|
+$30.1M |
3 |
Two Sigma Investments
New York
|
+$9.35M |
4 |
Two Sigma Advisers
New York
|
+$6.34M |
5 |
Renaissance Technologies
New York
|
+$5.81M |
Top Sellers
1 |
![]()
JPMorgan Chase & Co
New York
|
-$84.5M |
2 |
Invesco
Atlanta,
Georgia
|
-$19.4M |
3 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$16.8M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$13.8M |
5 |
BNP Paribas Asset Management
Paris,
France
|
-$3.67M |